U.S. Rule Enhances Out-of-Network Billing Dispute Resolution

The recent finalization of a rule by the U.S. administration aims to enhance the resolution process for disputes concerning out-of-network billing between insurers and healthcare providers. Although it marks an incremental improvement, the insurance industry notes that it does not fully tighten regulatory compliance requirements around these processes.

Initially developed during the Trump administration, the rule refines the No Surprises Act of 2020, legislation crafted to shield consumers from unexpected medical charges. While the Act effectively mitigated surprise billing, it inadvertently empowered certain healthcare entities to demand higher compensation via dispute resolution mechanisms.

James Gelfand, CEO of the ERISA Industry Committee, expressed concerns that the rule fails to address an imbalance perceived by insurers, favoring providers in dispute resolutions. Statistics show providers winning 88% of arbitration cases, often receiving compensation above standard in-network rates, raising underwriting questions among insurance carriers.

Arbitration Volume Challenges

The No Surprises Act initially projected about 17,000 arbitration cases annually. However, in the first half of 2025 alone, there were approximately 1.2 million disputes, largely driven by private-equity-affiliated organizations. This volume has triggered sustainability concerns, underscoring the need for robust risk management protocols among payers.

Insurance groups argue that the arbitration process suffers from insufficient oversight, with many disputes proceeding undeservedly. Reports indicate that in 2024, around 40% of cases were misallocated to this process, suggesting an inherent issue with current regulatory enforcement.

While the revised rule introduces measures to reduce ineligible cases and fosters enhanced communication between stakeholders, insurers had anticipated more stringent oversight. Proposals for further improvement involved greater scrutiny and transparency around arbitrators' operations.

Chris Bond of AHIP, a payer lobby group, acknowledges this rule as a significant step towards restructuring arbitration incentives. Yet, ongoing reform is essential to curb inflated billing practices, particularly those linked to private equity-backed healthcare providers.

Provider organizations welcomed the streamlined process improvements, including reduced filing fees that could aid smaller practices. Despite not overhauling the arbitration process, the changes are seen as progress. Carol Skenes from Turquoise Health noted that standardizing practices should reduce arbitration cases and help identify system misuses, introducing much-needed oversight.